New cases_status quo | ||||
---|---|---|---|---|
 | Stages I-II | Stage III | Stage IV | Total |
2023 | 198 | 297 | 495 | 991 |
2024 | 206 | 308 | 514 | 1028 |
2025 | 210 | 315 | 526 | 1051 |
2026 | 215 | 323 | 538 | 1075 |
2027 | 220 | 330 | 550 | 1100 |
Proposed scenario (20% reduction in current stage IV) | ||||
 | Stages I-II | Stage III | Stage IV | Total |
2023 | 351 | 244 | 396 | 991 |
2024 | 364 | 253 | 411 | 1028 |
2025 | 372 | 259 | 420 | 1051 |
2026 | 381 | 265 | 430 | 1075 |
2027 | 390 | 271 | 440 | 1100 |
Proposed scenario (50% reduction in current stage IV) | ||||
 | Stages I-II | Stage III | Stage IV | Total |
2023 | 499 | 244 | 248 | 991 |
2024 | 518 | 253 | 257 | 1028 |
2025 | 530 | 259 | 263 | 1051 |
2026 | 542 | 265 | 269 | 1075 |
2027 | 555 | 271 | 275 | 1100 |
Proposed scenario (70% reduction in current stage IV)* | ||||
 | Stages I-II | Stage III | Stage IV | Total |
2023 | 598 | 244 | 149 | 991 |
2024 | 621 | 253 | 154 | 1028 |
2025 | 635 | 259 | 158 | 1051 |
2026 | 649 | 265 | 161 | 1075 |
2027 | 665 | 271 | 165 | 1100 |
Proposed scenario (early diagnosis by five years) | ||||
2023 | 2119 | 244 | 149 | 2512 |